Good morning, folks, and how are you today? Another busy morning is underway here on the Pharmalot campus, where we have hustled the shortest of short people to the school bus and tended to the official mascots. Amid the chaos, we have managed to update our to-do list and look about for interesting developments. No doubt, you have a full agenda, as well. So, no time to dillydally. Here are the latest tidbits. Hope you conquer the world and drop us a line when something interesting occurs …
Carl Icahn has bought an undisclosed stake in Bristol-Myers Squibb, adding pressure on the drug maker, which is already reeling from setbacks in testing a key cancer drug, the Wall Street Journal reports. On Tuesday, the company added three independent directors to its board to appease Jana Partners, an activist investor that recently began buying up Bristol shares.
About the Author Reprints
